Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis

Trial Profile

Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Jan 2015

At a glance

  • Drugs Fingolimod (Primary) ; Glatiramer acetate; Interferon beta; Interferon beta
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jan 2015 The number of treatment arms has been increased from 1 to 2 to include comparator (interferon beta and glatiramer acetate) drugs, according to European Clinical Trials Database record.
    • 12 Jan 2015 Status changed from planning to recruiting as reported by European Clinical Trials Database record.
    • 06 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top